August 8, 2024 by China Anti-Cancer Association the game-changer in targeted tumor immunotherapyTumor immunotherapy targeting Tpex. Credit: Cancer Biology & Medicine Progenitor exhausted CD8+ T (Tpex) cells have emerged as a pivotal component in tumor immunotherapy due to their unique ability to self-renew and rapidly proliferate. These cells have shown promise in expanding and differentiating...
